Tina Marie De Vries is EVP, Research & Development of RVL Pharmaceuticals plc. Currently has a direct ownership of 136,141 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on May 18, 2022, when has been sold 5,447 shares (Ordinary Shares) at a price of $1.4 per share, resulting in proceeds of $7,626. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
0% 3M change
0% 12M change
Total Value Held $0

Tina Marie deVries Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2022
SELL
Payment of exercise price or tax liability
$7,626 $1.4 p/Share
5,447 Reduced 3.85%
136,141 Ordinary Shares
Jan 24 2022
SELL
Payment of exercise price or tax liability
$10,856 $1.13 p/Share
9,607 Reduced 6.35%
141,588 Ordinary Shares
May 18 2021
SELL
Payment of exercise price or tax liability
$20,177 $3.12 p/Share
6,467 Reduced 4.1%
151,195 Ordinary Shares
Jan 24 2021
SELL
Payment of exercise price or tax liability
$42,803 $4.46 p/Share
9,597 Reduced 5.74%
157,662 Ordinary Shares
TMd

Tina Marie De Vries

EVP, Research & Development
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP